SILEX Systems Ltd (SLX)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 3.390 |
|---|---|
| 52-week range | 3.380 – 10.850 |
| Return, 1 month / 3 months | −27.3% / −28.9% |
| Return, 1 year / 3 years | −56.2% / +8.3% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 84.5% |
| Worst drawdown (1 year) | -67.7% |
| Average daily value traded | 5.44M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Silex Systems is an Australian technology company based in Sydney that develops and commercialises laser-based uranium enrichment technology, working with partners to bring the process to industrial use. It also pursues advanced silicon technology for quantum computing through a subsidiary. Its customers and partners are mainly in the nuclear fuel and semiconductor industries, and its work centres on licensing and developing these technologies rather than manufacturing conventional products.
The shares are listed on the Australian Securities Exchange in Australia under the code SLX, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SILEX Systems Ltd (SLX) trades on the Australian Securities Exchange in Australia. It last closed at AUD 3.390 on 22 October 2026.
Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 1,267 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 56.2% and over the last three months it fell 28.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 22 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -38.6% | ||
| From 52-week high | -67.7% | ||
| Momentum | 20 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -28.9% | ||
| 6-month return | -45.1% | ||
| 12-month return, skipping the last month | -39.8% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 84.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -67.7% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 5.44M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.6% |
|---|---|
| 1 month | −27.3% |
| 3 months | −28.9% |
| 6 months | −45.1% |
| 1 year | −56.2% |
| 3 years | +8.3% |
| 5 years | +143.9% |
Signals
| 50-day / 200-day average | 4.596 / 5.525 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.248 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.